Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
osteoporotic fractures
MeSH D058866 - osteoporotic fractures
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D050723:
Bone fractures
9 Companies
3 Drugs
$
Success rate
D058866:
Osteoporotic fractures
2 Companies
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
Amgen
Denosumab
Prolia
2010-05-26
$4,316 M
Q4/23-Q3/24
Denosumab
Xgeva
2010-06-01
$2,191 M
Q4/23-Q3/24
Clinical Trials
Historical Success Rate
Phase 1
0
%
0/0
Phase 2
0
%
0/0
Phase 3
50
%
1/2
Approved:
1
Overall Success rate:
0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Amgen
Denosumab
Sandoz
Denosumab
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use
